$OCUL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OCULAR THERAPEUTIX, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in OCULAR THERAPEUTIX, INC. Get notifications about new insider transactions in OCULAR THERAPEUTIX, INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2021 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Option Exercise | A | 13.51 | 18,000 | 243,180 | 18,000 | |
| Jun 22 2021 | OCUL | OCULAR THERAPEUTIX ... | PEACOCK BRUCE | Director | Option Exercise | A | 13.51 | 18,000 | 243,180 | 18,000 | |
| Jun 22 2021 | OCUL | OCULAR THERAPEUTIX ... | LINDSTROM RICHARD L MD | Director | Option Exercise | A | 13.51 | 18,000 | 243,180 | 18,000 | |
| Jun 22 2021 | OCUL | OCULAR THERAPEUTIX ... | Hong Seung Suh | Director | Option Exercise | A | 13.51 | 18,000 | 243,180 | 18,000 | |
| Feb 19 2021 | OCUL | OCULAR THERAPEUTIX ... | Goldstein Michael H. | President, Ophthalm ... | Option Exercise | A | 18.31 | 250,000 | 4,577,500 | 250,000 | |
| Feb 19 2021 | OCUL | OCULAR THERAPEUTIX ... | Kitchen Patricia | Chief Operating Off ... | Option Exercise | A | 18.31 | 220,000 | 4,028,200 | 220,000 | |
| Feb 19 2021 | OCUL | OCULAR THERAPEUTIX ... | Mattessich Antony C. | President and CEO | Option Exercise | A | 18.31 | 455,000 | 8,331,050 | 455,000 | |
| Feb 17 2021 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Sell | J | 0.00 | 8,604 | 0 | 0 | 8.6 K to 0 (-100.00 %) |
| Feb 17 2021 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Buy | J | 0.00 | 35,912 | 0 | 39,531 | 3.6 K to 39.5 K (+992.32 %) |
| Feb 17 2021 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Sell | J | 0.00 | 375,121 | 0 | 0 | 375.1 K to 0 (-100.00 %) |
| Feb 17 2021 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Buy | J | 0.00 | 375,121 | 0 | 375,121 | 0 to 375.1 K |
| Feb 17 2021 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Sell | J | 0.00 | 1,456,780 | 0 | 0 | 1.5 M to 0 (-100.00 %) |
| Dec 08 2020 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Sell | J | 0.00 | 4,403 | 0 | 8,604 | 13 K to 8.6 K (-33.85 %) |
| Dec 08 2020 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Buy | J | 0.00 | 3,619 | 0 | 3,619 | 0 to 3.6 K |
| Dec 08 2020 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Sell | J | 0.00 | 37,208 | 0 | 0 | 37.2 K to 0 (-100.00 %) |
| Dec 08 2020 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Buy | J | 0.00 | 37,208 | 0 | 37,208 | 0 to 37.2 K |
| Dec 08 2020 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Sell | J | 0.00 | 745,597 | 0 | 1,456,780 | 2.2 M to 1.5 M (-33.85 %) |
| Dec 07 2020 | OCUL | OCULAR THERAPEUTIX ... | PEACOCK BRUCE | Director | Option Exercise | M | 8.14 | 7,000 | 56,980 | 11,000 | |
| Dec 07 2020 | OCUL | OCULAR THERAPEUTIX ... | PEACOCK BRUCE | Director | Option Exercise | M | 8.14 | 7,000 | 56,980 | 11,000 | |
| Dec 07 2020 | OCUL | OCULAR THERAPEUTIX ... | PEACOCK BRUCE | Director | Option Exercise | M | 3.90 | 18,000 | 70,200 | 0 | |
| Dec 07 2020 | OCUL | OCULAR THERAPEUTIX ... | PEACOCK BRUCE | Director | Option Exercise | M | 3.90 | 18,000 | 70,200 | 0 | |
| Dec 07 2020 | OCUL | OCULAR THERAPEUTIX ... | PEACOCK BRUCE | Director | Sell | S | 0.00 | 25,000 | 0 | 0 | 25 K to 0 (-100.00 %) |
| Dec 07 2020 | OCUL | OCULAR THERAPEUTIX ... | PEACOCK BRUCE | Director | Sell | S | 0.00 | 25,000 | 0 | 0 | 25 K to 0 (-100.00 %) |
| Dec 07 2020 | OCUL | OCULAR THERAPEUTIX ... | PEACOCK BRUCE | Director | Buy | M | 8.14 | 7,000 | 56,980 | 25,000 | 18 K to 25 K (+38.89 %) |
| Dec 07 2020 | OCUL | OCULAR THERAPEUTIX ... | PEACOCK BRUCE | Director | Buy | M | 8.14 | 7,000 | 56,980 | 25,000 | 18 K to 25 K (+38.89 %) |
| Dec 07 2020 | OCUL | OCULAR THERAPEUTIX ... | PEACOCK BRUCE | Director | Buy | M | 3.90 | 18,000 | 70,200 | 18,000 | 0 to 18 K |
| Dec 07 2020 | OCUL | OCULAR THERAPEUTIX ... | PEACOCK BRUCE | Director | Buy | M | 3.90 | 18,000 | 70,200 | 18,000 | 0 to 18 K |
| Oct 20 2020 | OCUL | OCULAR THERAPEUTIX ... | SUMMER ROAD LLC | 10% Owner | Buy | P | 10.48 | 437 | 4,580 | 5,618,861 | 5.6 M to 5.6 M (+0.01 %) |
| Oct 06 2020 | OCUL | OCULAR THERAPEUTIX ... | Strassburger Philip C. | General Counsel | Option Exercise | A | 8.42 | 350,000 | 2,947,000 | 350,000 | |
| Jun 26 2020 | OCUL | OCULAR THERAPEUTIX ... | Williams Leslie J. | Director | Option Exercise | A | 8.75 | 18,000 | 157,500 | 18,000 | |
| Jun 26 2020 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Option Exercise | A | 8.75 | 18,000 | 157,500 | 18,000 | |
| Jun 26 2020 | OCUL | OCULAR THERAPEUTIX ... | Heier Jeffrey S. | Director | Option Exercise | A | 8.75 | 18,000 | 157,500 | 18,000 | |
| Jun 26 2020 | OCUL | OCULAR THERAPEUTIX ... | PEACOCK BRUCE | Director | Option Exercise | A | 8.75 | 18,000 | 157,500 | 18,000 | |
| May 21 2020 | OCUL | OCULAR THERAPEUTIX ... | SUMMER ROAD LLC | 10% Owner | Buy | P | 5.50 | 363,636 | 1,999,998 | 5,618,424 | 5.3 M to 5.6 M (+6.92 %) |
| Mar 24 2020 | OCUL | OCULAR THERAPEUTIX ... | SUMMER ROAD LLC | 10% Owner | Buy | P | 4.87 | 35,052 | 170,714 | 5,254,788 | 5.2 M to 5.3 M (+0.67 %) |
| Mar 24 2020 | OCUL | OCULAR THERAPEUTIX ... | SUMMER ROAD LLC | 10% Owner | Buy | P | 4.66 | 64,948 | 302,365 | 5,219,736 | 5.2 M to 5.2 M (+1.26 %) |
| Mar 24 2020 | OCUL | OCULAR THERAPEUTIX ... | SUMMER ROAD LLC | 10% Owner | Buy | P | 4.52 | 9,100 | 41,119 | 5,154,788 | 5.1 M to 5.2 M (+0.18 %) |
| Mar 20 2020 | OCUL | OCULAR THERAPEUTIX ... | SUMMER ROAD LLC | 10% Owner | Buy | P | 4.63 | 40,900 | 189,224 | 5,145,688 | 5.1 M to 5.1 M (+0.80 %) |
| Mar 20 2020 | OCUL | OCULAR THERAPEUTIX ... | SUMMER ROAD LLC | 10% Owner | Buy | P | 4.62 | 344,938 | 1,594,200 | 5,104,788 | 4.8 M to 5.1 M (+7.25 %) |
| Mar 20 2020 | OCUL | OCULAR THERAPEUTIX ... | SUMMER ROAD LLC | 10% Owner | Buy | P | 4.63 | 40,900 | 189,224 | 5,145,688 | 5.1 M to 5.1 M (+0.80 %) |
| Mar 20 2020 | OCUL | OCULAR THERAPEUTIX ... | SUMMER ROAD LLC | 10% Owner | Buy | P | 4.62 | 344,938 | 1,594,200 | 5,104,788 | 4.8 M to 5.1 M (+7.25 %) |
| Mar 17 2020 | OCUL | OCULAR THERAPEUTIX ... | SUMMER ROAD LLC | 10% Owner | Buy | P | 4.66 | 550,000 | 2,562,890 | 4,759,850 | 4.2 M to 4.8 M (+13.06 %) |
| Mar 17 2020 | OCUL | OCULAR THERAPEUTIX ... | SUMMER ROAD LLC | 10% Owner | Buy | P | 4.16 | 194,262 | 807,217 | 4,209,850 | 4 M to 4.2 M (+4.84 %) |
| Mar 17 2020 | OCUL | OCULAR THERAPEUTIX ... | SUMMER ROAD LLC | 10% Owner | Buy | P | 4.63 | 210,800 | 975,983 | 4,015,588 | 3.8 M to 4 M (+5.54 %) |
| Feb 03 2020 | OCUL | OCULAR THERAPEUTIX ... | Mattessich Antony C. | President and CEO | Option Exercise | A | 4.39 | 360,000 | 1,580,400 | 360,000 | |
| Feb 03 2020 | OCUL | OCULAR THERAPEUTIX ... | Kitchen Patricia | Chief Operations Of ... | Option Exercise | A | 4.39 | 215,000 | 943,850 | 215,000 | |
| Feb 03 2020 | OCUL | OCULAR THERAPEUTIX ... | Notman Donald | Chief Financial Off ... | Option Exercise | A | 4.39 | 215,000 | 943,850 | 215,000 | |
| Feb 03 2020 | OCUL | OCULAR THERAPEUTIX ... | Goldstein Michael H. | Chief Medical Offic ... | Option Exercise | A | 4.39 | 215,000 | 943,850 | 215,000 | |
| Jan 03 2020 | OCUL | OCULAR THERAPEUTIX ... | Opaleye Management Inc. | 10% Owner | Buy | P | 3.90 | 15,000 | 58,508 | 4,918,500 | 4.9 M to 4.9 M (+0.31 %) |
| Jan 02 2020 | OCUL | OCULAR THERAPEUTIX ... | Opaleye Management Inc. | 10% Owner | Buy | P | 3.97 | 5,000 | 19,853 | 207,500 | 202.5 K to 207.5 K (+2.47 %) |
| Jan 02 2020 | OCUL | OCULAR THERAPEUTIX ... | Opaleye Management Inc. | 10% Owner | Buy | P | 3.97 | 15,000 | 59,558 | 4,903,500 | 4.9 M to 4.9 M (+0.31 %) |
| Jul 03 2019 | OCUL | OCULAR THERAPEUTIX ... | Kitchen Patricia | Chief Operations Of ... | Option Exercise | A | 4.62 | 150,000 | 693,000 | 150,000 | |
| Jun 17 2019 | OCUL | OCULAR THERAPEUTIX ... | Notman Donald | Chief Financial Off ... | Buy | P | 4.33 | 2,500 | 10,825 | 24,049 | 21.5 K to 24 K (+11.60 %) |
| Jun 17 2019 | OCUL | OCULAR THERAPEUTIX ... | Williams Leslie J. | Director | Buy | P | 4.40 | 4,500 | 19,800 | 4,500 | 0 to 4.5 K |
| Jun 13 2019 | OCUL | OCULAR THERAPEUTIX ... | Hong Seung Suh | Director | Option Exercise | A | 3.90 | 36,000 | 140,400 | 36,000 | |
| Jun 13 2019 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Option Exercise | A | 3.90 | 18,000 | 70,200 | 18,000 | |
| Jun 13 2019 | OCUL | OCULAR THERAPEUTIX ... | PEACOCK BRUCE | Director | Option Exercise | A | 3.90 | 18,000 | 70,200 | 18,000 | |
| Jun 13 2019 | OCUL | OCULAR THERAPEUTIX ... | Heier Jeffrey S. | Director | Option Exercise | A | 3.90 | 18,000 | 70,200 | 18,000 | |
| Jun 13 2019 | OCUL | OCULAR THERAPEUTIX ... | LINDSTROM RICHARD L MD | Director | Option Exercise | A | 3.90 | 18,000 | 70,200 | 18,000 | |
| Jun 10 2019 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | Chairman of the Boa ... | Buy | P | 3.02 | 65,468 | 197,713 | 1,056,031 | 990.6 K to 1.1 M (+6.61 %) |
| Jun 10 2019 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | Chairman of the Boa ... | Buy | P | 2.80 | 59,000 | 165,200 | 990,563 | 931.6 K to 990.6 K (+6.33 %) |
| Jun 10 2019 | OCUL | OCULAR THERAPEUTIX ... | Mattessich Antony C. | President & CEO | Buy | P | 2.81 | 40,000 | 112,400 | 97,900 | 57.9 K to 97.9 K (+69.08 %) |
| Jun 06 2019 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | Chairman of the Boa ... | Buy | P | 2.91 | 32,852 | 95,599 | 931,563 | 898.7 K to 931.6 K (+3.66 %) |
| Jun 06 2019 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | Chairman of the Boa ... | Buy | P | 2.92 | 12,928 | 37,750 | 898,711 | 885.8 K to 898.7 K (+1.46 %) |
| May 30 2019 | OCUL | OCULAR THERAPEUTIX ... | Goldstein Michael H. | Chief Medical Offic ... | Buy | P | 2.51 | 12,000 | 30,120 | 25,686 | 13.7 K to 25.7 K (+87.68 %) |
| Mar 22 2019 | OCUL | OCULAR THERAPEUTIX ... | Williams Leslie J. | Director | Option Exercise | A | 4.16 | 36,000 | 149,760 | 36,000 | |
| Mar 18 2019 | OCUL | OCULAR THERAPEUTIX ... | Heier Jeffrey S. | Director | Buy | P | 4.15 | 24,000 | 99,600 | 24,000 | 0 to 24 K |
| Mar 18 2019 | OCUL | OCULAR THERAPEUTIX ... | Goldstein Michael H. | Chief Medical Offic ... | Buy | P | 4.15 | 10,000 | 41,500 | 13,686 | 3.7 K to 13.7 K (+271.30 %) |
| Mar 14 2019 | OCUL | OCULAR THERAPEUTIX ... | LINDSTROM RICHARD L MD | Director | Buy | P | 4.33 | 56,441 | 244,390 | 100,000 | 43.6 K to 100 K (+129.57 %) |
| Jan 04 2019 | OCUL | OCULAR THERAPEUTIX ... | Bollag Daniel M | Sr. VP Reg. Affairs ... | Option Exercise | A | 4.10 | 180,000 | 738,000 | 180,000 | |
| Jan 04 2019 | OCUL | OCULAR THERAPEUTIX ... | Hanley Kevin F. | Sr. VP Technical Op ... | Option Exercise | A | 4.10 | 50,000 | 205,000 | 50,000 | |
| Jan 04 2019 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | Director | Option Exercise | A | 4.10 | 200,000 | 820,000 | 200,000 | |
| Jan 04 2019 | OCUL | OCULAR THERAPEUTIX ... | Notman Donald | Chief Financial Off ... | Option Exercise | A | 4.10 | 150,000 | 615,000 | 150,000 | |
| Jan 04 2019 | OCUL | OCULAR THERAPEUTIX ... | Mattessich Antony C. | President and CEO | Option Exercise | A | 4.10 | 400,000 | 1,640,000 | 400,000 | |
| Jan 04 2019 | OCUL | OCULAR THERAPEUTIX ... | Goldstein Michael H. | Chief Medical Offic ... | Option Exercise | A | 4.10 | 150,000 | 615,000 | 150,000 | |
| Dec 18 2018 | OCUL | OCULAR THERAPEUTIX ... | Hanley Kevin F. | See Remarks | Buy | P | 5.50 | 10,000 | 55,000 | 20,000 | 10 K to 20 K (+100.00 %) |
| Dec 12 2018 | OCUL | OCULAR THERAPEUTIX ... | Hanley Kevin F. | SEE REMARKS | Buy | P | 5.60 | 10,000 | 56,000 | 10,000 | 0 to 10 K |
| Dec 10 2018 | OCUL | OCULAR THERAPEUTIX ... | Bollag Daniel M | See Remarks | Buy | P | 5.76 | 17,400 | 100,224 | 42,100 | 24.7 K to 42.1 K (+70.45 %) |
| Aug 21 2018 | OCUL | OCULAR THERAPEUTIX ... | Mattessich Antony C. | President & CEO | Buy | P | 5.95 | 20,000 | 119,000 | 57,900 | 37.9 K to 57.9 K (+52.77 %) |
| Aug 15 2018 | OCUL | OCULAR THERAPEUTIX ... | Notman Donald | Chief Financial Off ... | Buy | P | 6.29 | 12,500 | 78,625 | 17,300 | 4.8 K to 17.3 K (+260.42 %) |
| Aug 13 2018 | OCUL | OCULAR THERAPEUTIX ... | Mattessich Antony C. | President and CEO | Buy | P | 6.23 | 16,900 | 105,287 | 37,900 | 21 K to 37.9 K (+80.48 %) |
| Aug 13 2018 | OCUL | OCULAR THERAPEUTIX ... | Mattessich Antony C. | President and CEO | Buy | P | 6.23 | 16,900 | 105,287 | 37,900 | 21 K to 37.9 K (+80.48 %) |
| Jun 15 2018 | OCUL | OCULAR THERAPEUTIX ... | Heier Jeffrey S. | Director | Option Exercise | A | 8.14 | 18,000 | 146,520 | 18,000 | |
| Jun 15 2018 | OCUL | OCULAR THERAPEUTIX ... | OSHEA WILLIAM J | Director | Option Exercise | A | 8.14 | 18,000 | 146,520 | 18,000 | |
| Jun 15 2018 | OCUL | OCULAR THERAPEUTIX ... | PEACOCK BRUCE | Director | Option Exercise | A | 8.14 | 18,000 | 146,520 | 18,000 | |
| Jun 15 2018 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Option Exercise | A | 8.14 | 18,000 | 146,520 | 18,000 | |
| Jun 15 2018 | OCUL | OCULAR THERAPEUTIX ... | Chadha Jaswinder | Director | Option Exercise | A | 8.14 | 18,000 | 146,520 | 18,000 | |
| Jun 15 2018 | OCUL | OCULAR THERAPEUTIX ... | LINDSTROM RICHARD L MD | Director | Option Exercise | A | 8.14 | 18,000 | 146,520 | 18,000 | |
| Feb 07 2018 | OCUL | OCULAR THERAPEUTIX ... | Hanley Kevin F. | Senior V.P.,Tech Op ... | Option Exercise | A | 5.01 | 125,000 | 626,250 | 125,000 | |
| Feb 02 2018 | OCUL | OCULAR THERAPEUTIX ... | Mattessich Antony C. | President and CEO | Option Exercise | A | 5.47 | 360,000 | 1,969,200 | 360,000 | |
| Feb 02 2018 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | Exec Chairman of th ... | Option Exercise | A | 5.47 | 130,000 | 711,100 | 130,000 | |
| Dec 22 2017 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | Exec Chairman of th ... | Option Exercise | M | 2.73 | 106,382 | 290,423 | 0 | |
| Dec 22 2017 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | Exec Chairman of th ... | Option Exercise | M | 2.49 | 83,011 | 206,697 | 0 | |
| Dec 22 2017 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | Exec Chairman of th ... | Buy | M | 2.73 | 106,382 | 290,423 | 885,783 | 779.4 K to 885.8 K (+13.65 %) |
| Dec 22 2017 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | Exec Chairman of th ... | Buy | M | 2.49 | 83,011 | 206,697 | 779,401 | 696.4 K to 779.4 K (+11.92 %) |
| Dec 13 2017 | OCUL | OCULAR THERAPEUTIX ... | Mattessich Antony C. | President and C.E.O ... | Buy | P | 4.29 | 21,000 | 90,090 | 21,000 | 0 to 21 K |
| Dec 08 2017 | OCUL | OCULAR THERAPEUTIX ... | Notman Donald | Chief Financial Off ... | Buy | P | 4.00 | 4,800 | 19,200 | 4,800 | 0 to 4.8 K |
| Dec 08 2017 | OCUL | OCULAR THERAPEUTIX ... | Bollag Daniel M | See Remarks | Buy | P | 3.93 | 24,700 | 97,071 | 24,700 | 0 to 24.7 K |
| Nov 20 2017 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | Exec. Chairman of t ... | Buy | P | 5.18 | 19,000 | 98,420 | 696,390 | 677.4 K to 696.4 K (+2.80 %) |
| Oct 03 2017 | OCUL | OCULAR THERAPEUTIX ... | Notman Donald | Chief Financial Off ... | Option Exercise | A | 6.30 | 125,000 | 787,500 | 125,000 | |
| Aug 08 2017 | OCUL | OCULAR THERAPEUTIX ... | Bollag Daniel M | See Remarks | Option Exercise | A | 6.04 | 110,000 | 664,400 | 110,000 | |
| Jun 22 2017 | OCUL | OCULAR THERAPEUTIX ... | Mattessich Antony C. | Director | Option Exercise | A | 10.94 | 590,000 | 6,454,600 | 590,000 | |
| Jun 01 2017 | OCUL | OCULAR THERAPEUTIX ... | GARVEY JAMES M | Director | Option Exercise | A | 10.71 | 13,500 | 144,585 | 13,500 | |
| Jun 01 2017 | OCUL | OCULAR THERAPEUTIX ... | Chadha Jaswinder | Director | Option Exercise | A | 10.71 | 13,500 | 144,585 | 13,500 | |
| Jun 01 2017 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Option Exercise | A | 10.71 | 13,500 | 144,585 | 13,500 | |
| Jun 01 2017 | OCUL | OCULAR THERAPEUTIX ... | PEACOCK BRUCE | Director | Option Exercise | A | 10.71 | 13,500 | 144,585 | 13,500 | |
| Jun 01 2017 | OCUL | OCULAR THERAPEUTIX ... | OSHEA WILLIAM J | Director | Option Exercise | A | 10.71 | 13,500 | 144,585 | 13,500 | |
| Jun 01 2017 | OCUL | OCULAR THERAPEUTIX ... | LINDSTROM RICHARD L MD | Director | Option Exercise | A | 10.71 | 13,500 | 144,585 | 13,500 | |
| Jun 01 2017 | OCUL | OCULAR THERAPEUTIX ... | Heier Jeffrey S. | Director | Option Exercise | A | 10.71 | 13,500 | 144,585 | 13,500 | |
| Feb 10 2017 | OCUL | OCULAR THERAPEUTIX ... | Fortune James | Chief Operating Off ... | Option Exercise | A | 6.56 | 90,000 | 590,400 | 90,000 | |
| Feb 10 2017 | OCUL | OCULAR THERAPEUTIX ... | Talamo Jonathan H. | Chief Medical Offic ... | Option Exercise | A | 6.56 | 60,000 | 393,600 | 60,000 | |
| Feb 10 2017 | OCUL | OCULAR THERAPEUTIX ... | Smith W Bradford | CFO and Treasurer | Option Exercise | A | 6.56 | 90,000 | 590,400 | 90,000 | |
| Feb 10 2017 | OCUL | OCULAR THERAPEUTIX ... | Ankerud Eric | See Remarks | Option Exercise | A | 6.56 | 60,000 | 393,600 | 60,000 | |
| Feb 10 2017 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Option Exercise | A | 6.56 | 235,000 | 1,541,600 | 235,000 | |
| Dec 16 2016 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Buy | P | 7.85 | 45,300 | 355,605 | 677,390 | 632.1 K to 677.4 K (+7.17 %) |
| Nov 08 2016 | OCUL | OCULAR THERAPEUTIX ... | Hurley Charles Andrew | Chief Commercial Of ... | Option Exercise | A | 5.21 | 100,000 | 521,000 | 100,000 | |
| Aug 09 2016 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Option Exercise | M | 1.35 | 58,357 | 78,782 | 0 | |
| Aug 09 2016 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Option Exercise | M | 1.35 | 58,357 | 78,782 | 0 | |
| Aug 09 2016 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Option Exercise | M | 1.35 | 58,357 | 78,782 | 0 | |
| Aug 09 2016 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Buy | M | 1.35 | 58,357 | 78,782 | 632,090 | 573.7 K to 632.1 K (+10.17 %) |
| Aug 09 2016 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Buy | M | 1.35 | 58,357 | 78,782 | 632,090 | 573.7 K to 632.1 K (+10.17 %) |
| Aug 09 2016 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Buy | M | 1.35 | 58,357 | 78,782 | 632,090 | 573.7 K to 632.1 K (+10.17 %) |
| Jul 26 2016 | OCUL | OCULAR THERAPEUTIX ... | Talamo Jonathan H. | Chief Medical Offic ... | Option Exercise | A | 4.42 | 18,000 | 79,560 | 18,000 | |
| Jul 26 2016 | OCUL | OCULAR THERAPEUTIX ... | Talamo Jonathan H. | Chief Medical Offic ... | Option Exercise | A | 4.42 | 18,000 | 79,560 | 18,000 | |
| Jun 10 2016 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Buy | P | 6.70 | 10,000 | 67,000 | 573,733 | 563.7 K to 573.7 K (+1.77 %) |
| Jun 03 2016 | OCUL | OCULAR THERAPEUTIX ... | GARVEY JAMES M | Director | Option Exercise | A | 12.05 | 13,500 | 162,675 | 13,500 | |
| Jun 03 2016 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Option Exercise | A | 12.05 | 13,500 | 162,675 | 13,500 | |
| Jun 03 2016 | OCUL | OCULAR THERAPEUTIX ... | LINDSTROM RICHARD L MD | Director | Option Exercise | A | 12.05 | 13,500 | 162,675 | 13,500 | |
| Jun 03 2016 | OCUL | OCULAR THERAPEUTIX ... | Chadha Jaswinder | Director | Option Exercise | A | 12.05 | 13,500 | 162,675 | 13,500 | |
| Jun 03 2016 | OCUL | OCULAR THERAPEUTIX ... | PEACOCK BRUCE | Director | Option Exercise | A | 12.05 | 13,500 | 162,675 | 13,500 | |
| Jun 03 2016 | OCUL | OCULAR THERAPEUTIX ... | Heier Jeffrey S. | Director | Option Exercise | A | 12.05 | 13,500 | 162,675 | 13,500 | |
| Jun 03 2016 | OCUL | OCULAR THERAPEUTIX ... | OSHEA WILLIAM J | Director | Option Exercise | A | 12.05 | 13,500 | 162,675 | 13,500 | |
| Feb 04 2016 | OCUL | OCULAR THERAPEUTIX ... | Smith W Bradford | See Remarks | Option Exercise | A | 5.93 | 70,000 | 415,100 | 70,000 | |
| Feb 04 2016 | OCUL | OCULAR THERAPEUTIX ... | Ankerud Eric | See Remarks | Option Exercise | A | 5.93 | 57,500 | 340,975 | 57,500 | |
| Feb 04 2016 | OCUL | OCULAR THERAPEUTIX ... | Fortune James | Chief Operating Off ... | Option Exercise | A | 5.93 | 80,000 | 474,400 | 80,000 | |
| Feb 04 2016 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Option Exercise | A | 5.93 | 235,000 | 1,393,550 | 235,000 | |
| Nov 18 2015 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Buy | P | 8.25 | 10,000 | 82,500 | 563,733 | 553.7 K to 563.7 K (+1.81 %) |
| Nov 09 2015 | OCUL | OCULAR THERAPEUTIX ... | OSHEA WILLIAM J | Director | Option Exercise | A | 10.75 | 11,363 | 122,152 | 11,363 | |
| Sep 17 2015 | OCUL | OCULAR THERAPEUTIX ... | Fortune James | Chief Operating Off ... | Sell | S | 17.16 | 9,470 | 162,505 | 112,060 | 121.5 K to 112.1 K (-7.79 %) |
| Sep 16 2015 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Buy | P | 16.92 | 3,672 | 62,130 | 553,733 | 550.1 K to 553.7 K (+0.67 %) |
| Sep 16 2015 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Buy | P | 16.36 | 11,328 | 185,326 | 550,061 | 538.7 K to 550.1 K (+2.10 %) |
| Sep 15 2015 | OCUL | OCULAR THERAPEUTIX ... | Heier Jeffrey S. | Director | Option Exercise | A | 16.64 | 11,363 | 189,080 | 11,363 | |
| Jun 15 2015 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Sell | S | 22.00 | 1,878 | 41,316 | 13,007 | 14.9 K to 13 K (-12.62 %) |
| Jun 15 2015 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Sell | S | 22.00 | 318,122 | 6,998,684 | 2,202,377 | 2.5 M to 2.2 M (-12.62 %) |
| Jun 15 2015 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Sell | S | 22.00 | 1,878 | 41,316 | 13,007 | 14.9 K to 13 K (-12.62 %) |
| Jun 15 2015 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Sell | S | 22.00 | 318,122 | 6,998,684 | 2,202,377 | 2.5 M to 2.2 M (-12.62 %) |
| Jun 12 2015 | OCUL | OCULAR THERAPEUTIX ... | PEACOCK BRUCE | Director | Option Exercise | A | 22.54 | 5,681 | 128,050 | 5,681 | |
| Jun 12 2015 | OCUL | OCULAR THERAPEUTIX ... | Chadha Jaswinder | Director | Option Exercise | A | 22.54 | 5,681 | 128,050 | 5,681 | |
| Jun 12 2015 | OCUL | OCULAR THERAPEUTIX ... | LINDSTROM RICHARD L MD | Director | Option Exercise | A | 22.54 | 5,681 | 128,050 | 5,681 | |
| Jun 12 2015 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Option Exercise | A | 22.54 | 5,681 | 128,050 | 5,681 |